The American Association of Pharmaceutical Scientists (AAPS), a global powerhouse representing over 7,000 scientists and professionals dedicated...
Rifan Muazin
The landscape of breast cancer treatment is undergoing a fundamental paradigm shift. For decades, the primary objective...
AMMAN, Jordan – The World Health Organization (WHO) Director-General, Dr. Tedros Adhanom Ghebreyesus, has concluded a pivotal...
In a landmark study that challenges the conventional wisdom that "more oxygen is always better," researchers at...
For many breast cancer patients, the conclusion of active treatment—chemotherapy, radiation, or surgery—is often viewed as the...
The biotechnology and pharmaceutical sectors continue to navigate a period of intense scrutiny and rapid evolution. From...
In the landscape of modern drug discovery, a profound shift is occurring—not in the creation of new...
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
The biopharmaceutical landscape underwent a series of seismic shifts this week, characterized by intense scrutiny of high-profile...
By Douglas Feil, NBCF Chief Program Officer The landscape of chronic disease management has been significantly reshaped...
